About Cardinal
Cardinal is a Healthcare company based in Woburn (United States) founded in 2014, and was acquired by IPS in April 2019. Provider of research development and project management services for biopharma sector. Cardinal offers products and services including Owner Representation and Construction Services. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its legal entity is Cardinal Group USA, LLC. Its competitors include Pfizer, LabConnect and Matchpoint Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Cardinal was established in 2014 and is headquartered in Woburn, United States. Operations focus on the biopharma sector, where research and development services are delivered alongside project management support. These offerings assist clients in advancing drug development and managing complex initiatives. The companys domain, cardinalgroupusa.com, supports its U.S.-based activities in this specialized field.
- Headquarters Woburn, United States
- Stage Acquired
- SectorsHealthcare
- Website cardinalgroupusa.com
- Social LinkedIn
- Acquired by IPS (Apr 2019)
- Legal Name Cardinal Group Usa, Llc
Products & Services of Cardinal
Cardinal offers a comprehensive portfolio of products and services, including Owner Representation and Construction Services.
Manages risks and represents client interests in construction projects
Handles preconstruction to commissioning for specialized facilities
Investors in Cardinal
Cardinal has secured backing from 1 investor. Prominent investors backing the company include IPS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
EPCMV services are delivered in engineering and construction fields. | 1998 | ipsdb.com | Blue Bell, United States |
Investor details for Cardinal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cardinal
9 people are tracked at Cardinal (3 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Michael Sullivan | Vice President | Leadership |
Bill Held | President | Leadership |
Dana Niro | Project Director | Leadership |
Kevin Martinich | Senior MEP Manager | Team |
Nicholas Parsa (Nick) | Senior Project Controls Manager | Team |
Azim Ishmael | Sr Program/project Controls & CPM Scheduling Manager | Team |
Scott Klima | Manager Of Project Controls | Team |
Ronald Willhite | Environment, Health And Safety Manager | Team |
Mathew Gabak | Senior MEP Manager | Team |
Complete people profiles for Cardinal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cardinal
2 dated milestones of Cardinal across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cardinal is founded.
- Exit Acquired by IPS.
Competitors of Cardinal
Cardinal has 3 listed competitors in our database, 3 of them funded. They include Pfizer, LabConnect and Matchpoint Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| matchpointtx.com | 2021 | Cambridge, United States | $100M | 27 | Small molecule medicine development and analytics services are provided. |
Detailed competitors of Cardinal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cardinal (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cardinal
Cardinal was founded in 2014.
Cardinal is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Cardinal was established in 2014 and is headquartered in Woburn, United States. Operations focus on the biopharma sector, where research and development services are delivered alongside project management support. These offerings assist clients in advancing drug development and managing complex initiatives. The companys domain, cardinalgroupusa.com, supports its U.S.-based activities in this specialized field.
Cardinal's top competitors include Pfizer, LabConnect and Matchpoint Therapeutics.
Cardinal offers Owner Representation and Construction Services.
Cardinal has 1 investor. Key investors include IPS.
Cardinal operates through Cardinal Group Usa, Llc.
Yes. Cardinal was acquired by IPS in April 2019.
